Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder

Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder

US Patent 9132124 · Granted Sep 15, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulations2020
Pharmaceutical formulations2020
Controlled-release tozadenant formulations2020
Pharmaceutical formulations2018
Pharmaceutical formulations2018
Combinations of solifenacin and salivary stimulants for the treatment of overact2017
Combinations of solifenacin and salivary stimulants for the treatment of overact2017
Combinations of solifenacin and salivary stimulants for the treatment of overact2017
Combinations of solifenacin and salivary stimulants for the treatment of overact2017
Pharmaceutical formulations2016
Pharmaceutical formulations2016
Combinations of solifenacin and salivary stimulants for the treatment of overact2015